Alan Kohler interviews Dr Yacov's, page-65

Hi @happytrader2015,

LifeWatch AG had, in average, 50% gross margin but the cost of supporting the heart monitoring is higher and I believe they were using full absorpion cost, so the Prizma configuration and support should be cheaper and 70% should be achievable in my opinion, although I agree with you that once the other products start being commecialized then we should probably see a decrease. Remember that Yacov had extensive experience through many years in LifeWatch so he is not throwing any number over the table.

Cheers,